Index by author

December 01, 2013; Volume 80,Issue 12

  1. Saeed, Giovanni

    1. The FREEDOM trial (August 2013)
      Giovanni Saeed, MD, Rainer Gradaus, MD, PhD and Jörg Neuzner, MD, PhD
      Cleveland Clinic Journal of Medicine December 2013, 80 (12) 748-749; DOI: https://doi.org/10.3949/ccjm/80c.12001

      Readers comment on the FREEDOM trial (August 2013) and on electronic health records (July 2013).

  2. Seto, Arnold H.

    1. Third universal definition of myocardial infarction: Update, caveats, differential diagnoses
      David M. Tehrani, MS and Arnold H. Seto, MD, MPA
      Cleveland Clinic Journal of Medicine December 2013, 80 (12) 777-786; DOI: https://doi.org/10.3949/ccjm.80a.12158

      Troponin levels are elevated in nearly everyone having a myocardial infarction—but also in many who are not. Hence, clinical judgment is needed.

  3. Sharma, Prashant

    1. Can an ARB be given to patients who have had angioedema on an ACE inhibitor?
      Prashant Sharma, MD and Vijaiganesh Nagarajan, MD
      Cleveland Clinic Journal of Medicine December 2013, 80 (12) 755-757; DOI: https://doi.org/10.3949/ccjm.80a.13041

      Proceed with caution. ARBs can also cause angioedema, but the benefit may outweigh the risk if the patient truly needs the drug.

  4. Shishehbor, Mehdi H.

    1. In Reply: The FREEDOM trial (August 2013)
      Bhuvnesh Aggarwal, MD and Mehdi H. Shishehbor, DO, MPH, PhD
      Cleveland Clinic Journal of Medicine December 2013, 80 (12) 749; DOI: https://doi.org/10.3949/ccjm/80c.12002

      Readers comment on the FREEDOM trial (August 2013) and on electronic health records (July 2013).

  5. Silver, Brian

    1. Antiplatelet therapy to prevent recurrent stroke: Three good options
      Antiplatelet therapy to prevent recurrent stroke: Three good options
      Atizazul H. Mansoor, MD, Mohammad T. Mujtaba, MD and Brian Silver, MD
      Cleveland Clinic Journal of Medicine December 2013, 80 (12) 787-795; DOI: https://doi.org/10.3949/ccjm.80a.12149

      Aspirin, dipyridamole, and clopidogrel are important parts of therapy to prevent recurrent stroke of atherosclerotic origin.

Back to top

In this issue